Differential Efficacy of Advanced Therapies in Inducing Remission in Ulcerative Colitis Based on Prior Exposure to TNF Antagonists
Clinical Gastroenterology and Hepatology · 2025-11 · 23 (12) · 2102-2114.e5
DOI: 10.1016/j.cgh.2024.12.007 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025-11. Verfasst von Han Hee Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California; Division of Gastroenterology, Departm…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Tumor Necrosis Factor Inhibitors, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCCDPHP CDC HHS, NCATS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California; Division of Gastroenterology, Department of Internal Medicine, Yeouido St. Mary's Hospital College of Medic…
- Division of Gastroenterology, Department of Medicine, Western University, London, Ontario, Canada; Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS Ospedale San Raffaele, Università Vita-Salute San Raf…
- College of Human Medicine, Michigan State University, East Lansing, Michigan.
- Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
- Division of Gastroenterology, Department of Medicine, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
- Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California.
Förderung
- NCCDPHP CDC HHS
- NCATS NIH HHS
- NIDDK NIH HHS
- NIAID NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- Centers for Disease Control and Prevention
- National Institutes of Health
Zitieren
APA
Lee, H. H., Solitano, V., Singh, S., Ananthakrishnan, A. N., Jairath, V., Syal, G., Boland, B. S., Ghosh, P., Chang, J. T., & Singh, S. (2025). Differential Efficacy of Advanced Therapies in Inducing Remission in Ulcerative Colitis Based on Prior Exposure to TNF Antagonists. Clinical Gastroenterology and Hepatology, 23(12), 2102-2114.e5. https://doi.org/10.1016/j.cgh.2024.12.007
Vancouver
Lee HH, Solitano V, Singh S, Ananthakrishnan AN, Jairath V, Syal G, et al. Differential Efficacy of Advanced Therapies in Inducing Remission in Ulcerative Colitis Based on Prior Exposure to TNF Antagonists. Clinical Gastroenterology and Hepatology. 2025;23(12):2102-2114.e5. doi:10.1016/j.cgh.2024.12.007
BibTeX
@article{Lee2025,
author = {Lee, Han Hee and Solitano, Virginia and Singh, Sujay and Ananthakrishnan, Ashwin N and Jairath, Vipul and Syal, Gaurav and Boland, Brigid S and Ghosh, Pradipta and Chang, John T and Singh, Siddharth},
title = {Differential Efficacy of Advanced Therapies in Inducing Remission in Ulcerative Colitis Based on Prior Exposure to TNF Antagonists},
journal = {Clinical Gastroenterology and Hepatology},
year = {2025},
volume = {23},
number = {12},
pages = {2102--2114.e5},
doi = {10.1016/j.cgh.2024.12.007}
}
EUVIMED